Cooperative Mechanisms in IL-4-Induced Gene Expression
Cooperative Mechanisms in IL-4-Induced Gene Expression
批准号:
7146699
负责人:
MICHAEL T BERTON
金额:
$30.32万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-01 至 2008-11-30
关键词:
1-Phosphatidylinositol 3-KinaseAsthmaAutoimmune DiseasesB-LymphocytesBindingBiologicalBiological AssayCD4 Positive T LymphocytesCell LineCellsCessation of lifeComplexDNADataDevelopmentDiseaseDrug DesignEventGene ActivationGene ExpressionGene Expression ProfilingGene Expression RegulationGenesGenetic TranscriptionGoalsHypersensitivityIgEIgG1IgG4Immune responseImmunoglobulin Class SwitchingImmunoglobulin GenesIn VitroInfectionInflammatory ResponseInterleukin-4Janus kinaseKineticsKnockout MiceKnowledgeLaboratoriesLymphocyteMapsMass Spectrum AnalysisMediatingModelingMusNumbersOutcomePathway interactionsPeptide MappingPhosphorylationPhosphorylation SitePlayPrincipal InvestigatorProcessProtein-Serine-Threonine KinasesProteinsPublishingRangeRegulationResearchRetroviridaeRoleSerineSerine Phosphorylation SiteSignal PathwaySignal TransductionSiteT-LymphocyteTestingTh2 CellsTimeTransactivationTyrosine PhosphorylationWorkYeastsbasecell growthcell typecofactorcytokineexpectationimmune functionin vivomutantnovel strategiesprogramsprotein protein interactionreceptorresponsetranscription factoryeast two hybrid system
中文摘要
细胞因子IL-4是参与体液免疫发育和调控的最重要的细胞因子
英文摘要
The cytokine IL-4 is the single most important cytokine involved in the development and regulation of humoral immune
responses. IL-4 drives the differentiation of naive CD4+ T cells into T helper type 2 (Th2) cells, directs isotype switching in B
cells to IgE and IgG4 (IgG1 in mice), and regulates cell growth and death. As such, IL-4 has a pivotal role in regulating
inflammatory responses, autoimmune diseases, immune responses to infection, and allergy, including asthma. IL-4 regulates
this diverse array of immune functions in part through the activation of specific sets of genes in different cell types. IL-4
induces gene expression by inducing Janus kinase(Jak)-mediated activation of the transcription factor Stat6. Importantly,
binding of Stat6 alone to DNA is not sufficient to activate transcription and cooperation of Stat6 with other factors is necessary.
Recent evidence suggests that other signaling pathways, including the IRS-2/PI 3-kinase and PKC pathways, may be
important for Stat6-dependent gene expression, but how other pathways cooperate with Stat6 is entirely unknown. The
long-range goal of this project is to understand how IL-4 signaling regulates gene expression to mediate diverse biological
effects. The objective of this application is to elucidate the mechanisms by which the JakJStat6 pathway cooperates with other
signaling pathways and cellular factors to activate gene expression in response to IL-4. The central hypothesis for the
proposed research is that IL-4-respcnsive gene expression is regulated not only by Jak-mediated tyrosine phosphorylation of
Stat6 but also by serine kinase signaling pathways that converge on Stat6 and other required transcription cofactors to
aromote their cooperative interaction. This hypothesis is supported by our recent demonstration that IL-4 induces serine
ahosphorylation of Stat6. To test the central hypothesis, this proposal will pursue three specific aims: 1) determine the sites of
Star6 serine phosphorylation, the kinetics and stability of serine phosphorylation and the role of IL-4R-mediated signaling
events in Stat6 serine phosphorylation; 2) determine the role of IL-4-induced Stat6 serine phosphorylation in the regulation of
Stat6-dependent gene expression; and 3) establish the mechanisms by which Stat6 cooperates with other necessary cofactors
in the regulation of IL-4-dependent gene expression. Serine phosphorylation sites in Stat6 will be determined by peptide
mapping and mass spectrometry. Their role in regulating Stat6 expression and function will be analyzed in Stat6-deficient B
cells by retrovirus-mediated transduction. The proposed studies will focus on the regulation of the unrearranged IgG1
immunoglobulin gene in mouse B cells as a model for IL-4-induced gene expression. The proposed studies will significantly
advance our current limited understanding of how IL-4 signaling and Stat6 regulate gene expression in lymphocytes as well as
in other cell types. A better understanding of how IL-4-mediated signals cooperate to regulate gene expression will also allow
development of novel approaches for modulating immune responses and disease processes regulated or influenced by IL-4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FACSAria Fusion cell sorter for Flow Cytometry Shared Resource
-
批准号:10431534
-
项目类别:
-
资助金额:$59.6万
-
财政年份:2022
-
负责人:MICHAEL T BERTON
-
依托单位:
A novel role for the TLR signaling adaptor TRAM
-
批准号:8304012
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2012
-
负责人:MICHAEL T BERTON
-
依托单位:
A novel role for the TLR signaling adaptor TRAM
-
批准号:8535602
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2012
-
负责人:MICHAEL T BERTON
-
依托单位:
Toll-Like Receptors and Immunity to F. tularensis
-
批准号:6912411
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2005
-
负责人:MICHAEL T BERTON
-
依托单位:
Cooperative Mechanisms in IL-4-Induced Gene Expression
-
批准号:6821998
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Cooperative Mechanisms in IL-4-Induced Gene Expression
-
批准号:6685175
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Cooperative Mechanisms in IL-4-Induced Gene Expression
-
批准号:7006994
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Cooperative Mechanisms in IL-4-Induced Gene Expression
-
批准号:6576428
-
项目类别:
-
资助金额:$31.77万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Fluorescence, Chemiluminescence and Phosphor Imager
-
批准号:6440395
-
项目类别:
-
资助金额:$12.36万
-
财政年份:2002
-
负责人:MICHAEL T BERTON
-
依托单位:
Mays Cancer Center at UT Health SA
-
批准号:10237954
-
项目类别:
-
资助金额:$7.91万
-
财政年份:1997
-
负责人:MICHAEL T BERTON
-
依托单位:
Mays Cancer Center at UT Health SA
-
批准号:10025088
-
项目类别:
-
资助金额:$7.91万
-
财政年份:1997
-
负责人:MICHAEL T BERTON
-
依托单位:
Mays Cancer Center at UT Health SA
-
批准号:10460434
-
项目类别:
-
资助金额:$7.91万
-
财政年份:1997
-
负责人:MICHAEL T BERTON
-
依托单位:
Mays Cancer Center at UT Health SA
-
批准号:10653911
-
项目类别:
-
资助金额:$7.91万
-
财政年份:1997
-
负责人:MICHAEL T BERTON
-
依托单位:
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
-
批准号:2072511
-
项目类别:
-
资助金额:$9.37万
-
财政年份:1996
-
负责人:MICHAEL T BERTON
-
依托单位:
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
-
批准号:2886930
-
项目类别:
-
资助金额:$10.54万
-
财政年份:1996
-
负责人:MICHAEL T BERTON
-
依托单位:
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
-
批准号:2672358
-
项目类别:
-
资助金额:$10.13万
-
财政年份:1996
-
负责人:MICHAEL T BERTON
-
依托单位:
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
-
批准号:6170194
-
项目类别:
-
资助金额:$10.96万
-
财政年份:1996
-
负责人:MICHAEL T BERTON
-
依托单位:
CONTROL OF SWITCH RECOMBINATION BY CD40 LIGAND
-
批准号:2442606
-
项目类别:
-
资助金额:$9.74万
-
财政年份:1996
-
负责人:MICHAEL T BERTON
-
依托单位:
MECHANISM OF ISOTYPE SWITCHING IN MURINE B LYMPHOCYTES
-
批准号:3029956
-
项目类别:
-
资助金额:$2.6万
-
财政年份:1989
-
负责人:MICHAEL T BERTON
-
依托单位:
MECHANISM OF ISOTYPE SWITCHING IN MURINE B LYMPHOCYTES
-
批准号:3029957
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1989
-
负责人:MICHAEL T BERTON
-
依托单位:
海外基金